PDLIM2 and lung carcinoma: In summary, the presented data identify genetic deletions as a major mechanism other than epigenetic alterations for PDLIM2 repression in human lung cancer, and PDLIM2 as a haploinsufficient tumor suppressor particularly important for suppressing lung cancer and therapy resistance.